April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...
April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...
April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...
April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...
April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...
April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...
April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second ...
April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly ...
April 8, 2024 — People who have had a heart attack or who are at risk for a heart attack and who stopped taking aspirin ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
April 7, 2024 — Strategies such as earning points or small amounts of money encouraged people at high risk for heart ...
April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing ...
April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated ...
April 09, 2024
